| 发明名称 |
EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN CANCER PATIENTS |
| 摘要 |
The present application describes extending time to disease progression or survival in a cancer patient, where the patient's cancer displays HER activation, by treating the patient with a HER dimerization inhibitor, such as pertuzumab. |
| 申请公布号 |
US2015273059(A1) |
申请公布日期 |
2015.10.01 |
| 申请号 |
US201514740920 |
申请日期 |
2015.06.16 |
| 申请人 |
GENENTECH, INC. |
发明人 |
Derynck Mika K.;Kelsey Stephen M. |
| 分类号 |
A61K39/395;C07K16/32;A61K31/7068;A61K45/06 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for extending time to disease progression (TTP) or survival in a cancer patient comprising administering a HER dimerization inhibitor to the patient in an amount which extends TTP or survival in the patent, wherein the patient's cancer displays HER activation. |
| 地址 |
South San Francisco CA US |
